Cite
HARVARD Citation
Frezza, A. et al. (2020). Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network. Cancer. 126 (1), pp. 98-104. [Online].